Ebola Outbreak in Congo Surpasses 9,000 Cases as Second Largest in History

2026-10-14 region

Kinshasa, 14 October 2026
Congo’s Ebola outbreak has exceeded 9,000 cases, becoming the country’s worst on record. With no approved treatments for this strain, mortality rates exceed 48 per cent.

Unprecedented Escalation Across the Democratic Republic of Congo

The Democratic Republic of Congo is facing an escalating public health emergency as its 17th Ebola outbreak officially became the worst in the nation’s history [4]. Officially declared on 15 May 2026, experts suggest the virus may have been circulating undetected for weeks or months prior to its formal identification [1][5]. As of 13 October 2026, official figures from the Congolese National Institute of Public Health record 9,066 total cases and 4,381 deaths [1][5]. Alternative epidemiological updates as of 12 October 2026 place the toll even higher at 9,144 confirmed cases and 4,410 fatalities, with 899 individuals remaining in hospital isolation and 2,418 recoveries recorded [2]. This surge translates to a severe case-fatality rate of 48.323% based on national reporting, cementing its status as the second-largest Ebola outbreak recorded globally, surpassed only by the West African epidemic of 2014 to 2016 [1][4].

Therapeutic Deficits and Secondary Health Crises

A major driver of the outbreak’s severity is the causative agent itself: the Bundibugyo strain of the Ebola virus [1][2][4]. Unlike the Zaire strain, for which monoclonal antibody treatments such as Inmazeb and Ebanga were previously approved by the US FDA, there are currently no approved vaccines or targeted therapies for the Bundibugyo species [1][4][6]. To address this gap, the Coalition for Epidemic Preparedness Innovations (CEPI) has initiated the ‘Tumaini’ phase 2/3 adaptive platform trial to evaluate multiple candidates [1]. Concurrently, Medecins Sans Frontieres is coordinating the ‘Bravo’ study in North Kivu and Ituri, testing the cross-reactivity of the Ervebo vaccine; as of 10 October 2026, 857 frontline healthcare workers had been vaccinated under this clinical trial framework [1][5].

Cross-Border Transmission and International Preparedness

The movement of people across East Africa has led to sporadic regional spillovers [2][4]. Although Uganda successfully declared an end to its local outbreak on 25 August 2026 following a 42-day period without new transmission, cross-border risks remain active [1][2]. On 6 October 2026, Kenya confirmed an imported Ebola case after a citizen travelled from the DRC via Uganda on 3 October and subsequently died in Nairobi [2][4]. Kenyan health authorities quickly isolated 108 out of 122 listed contacts by 11 October 2026, reporting no secondary symptoms among them so far [2]. Medical evacuations of exposed or infected healthcare personnel have also been carried out to Europe and North America, including an evacuation to Leiden University Medical Center in the Netherlands on 1 October 2026 [2].

Bronnen

Ebola outbreak DR Congo